Myriad UroSuite?

Four brilliant minds took the stage at #ACRO25, leading an insightful panel on biomarkers and genetic testing in prostate cancer care. With a room full of engaged radiation oncologists from across the nation, the discussion highlighted: ? How biomarkers like Prolaris? guide treatment decisions ? The importance of germline testing in a comprehensive patient workup ? The future of genetic/genomic testing in personalizing care At Myriad Genetics, we are committed to supporting radiation oncologists and advancing precision medicine through our partnership with ACRO - American College of Radiation Oncology. #ProstateCancer #GeneticTesting #RadiationOncology #Biomarkers

Exciting news from #ACRO25! ?? As a Gold Sponsor, we’re loving the enthusiasm at our booth from radiation oncologists who are interested in exploring genetic testing in prostate cancer. If you're attending, don’t miss the chance to stop by Booth #313 to learn more. We're looking forward to a great meeting! ACRO - American College of Radiation Oncology Sunny Yarrish Brooke Hart Terry White Rob Finch Michael Irelan Jef Reyburn, MBA #ProstateCancer #GeneticTesting #RadiationOncology #Biomarkers

Navigating prostate cancer decisions can be challenging. Our dedicated customer service representatives are here to provide the resources and support to help you and your patients make informed treatment decisions with confidence. Learn more: https://brnw.ch/21wRhOj #prostatecancer #urology #onocology #biomarkers #genetictesting

In the latest episode of the Precision Oncology and Prostate Cancer: The New Standard of Care miniseries, Dr. Paul Sieber and Ashleigh Renitsky, Oncology PA, welcome special guest Dr. David Morris. These industry experts discuss how germline and somatic testing can help personalize treatment strategies and share real world case studies. Listen today! https://brnw.ch/21wRgab #ProstateCancer #GeneticTesting #GeneticInsights #PrecisionMedicine

?? We’re two days away from #ACRO2025! Don’t miss our lunch symposium Expert Panel: Role of Genomics and Genetics in Prostate Cancer on Friday, March 14th from 12:25-1:15 p.m. in room Celebrity 7. Meet our panelists: ?? Dr. Christopher Lee, Radiation Oncologist, Cancer Care Northwest ?? Dr. Alvaro Martinez, Radiation Oncologist, MHP Radiation Oncology Institute ?? Dr. Daniel Kim, Radiation Oncologist, Inova Schar Cancer Institute ?? Dr. Steven Finkelstein, Radiation Oncologist, AMP Urology Stop by booth # 313 to learn more. See you in Las Vegas! #ACROinVegas #AcingCancerCare #RadOnc

Timing matters when making prostate cancer treatment decisions. With a quick turnaround time, the Prolaris? test can deliver genetic insights in time for your patient’s cancer consultation—helping guide a more informed discussion. Learn more about the Prolaris test today! https://lnkd.in/gcY7wjeU #PrecisionMedicine #ProstateCancerCare #GeneticTesting #Biomarkers #Urology

Our team is gearing up for #ACRO2025 in Las Vegas! ??? Don’t miss our expert panel during Myriad’s lunch symposium!? “Role of Genomics and Genetics in Prostate Cancer” ?? Friday, March 14 | ?? 12:25-1:15 p.m. | ?? Room Celebrity 7 Join us for an insightful discussion on the power of genomics in radiation oncology and its role in advancing patient outcomes. ?? Register now: acro.org/annual_meeting #ACROinVegas #AcingCancerCare #RadOnc?

The Prolaris? test provides clear, easy-to-understand results that help guide prostate cancer treatment decisions. With a straightforward report, you and your patients can have more informed conversations about the best path forward. Learn more: https://brnw.ch/21wR6AS #ProstateCancer #Biomarkers #GeneticTesting #Urology

Making treatment decisions is easier with the right tools. The Prolaris? test can identify which men are safe for active surveillance and those who should pursue definitive treatment. testing can also identify which patients should consider actively treating their cancer with one form of treatment, like surgery or radiation, and which patients will benefit from multiple forms of treatment. Learn more: https://brnw.ch/21wR1We #ProstateCancer #Biomarkers #GeneticTesting #Urology

Thank you Urology Times for highlighting the exciting new collaboration between Myriad Genetics and PATHOMIQ, Inc.! We are thrilled about the impact this #innovation will have on #patientcare. ?? See more from Urology Times: https://lnkd.in/gvQ2_-vV ?? If you haven't yet, read the official press release: https://lnkd.in/g7BdJjhy #precisionmedicine #prostatecancer #oncology